Search for an ETF or holding
VAXIL BIO LTD (VXL.V) is a Canadian company in the healthcare sector, listed on TSXV. Market capitalization of 916,324.6 CAD (micro-cap).
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. Its lead product candidate is ImMucin, a MUC1 SP-based vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. The company is headquartered in Toronto, Canada.